Page last updated: 2024-08-17

chloramphenicol and tolbutamide

chloramphenicol has been researched along with tolbutamide in 36 studies

Research

Studies (36)

TimeframeStudies, this research(%)All Research%
pre-199020 (55.56)18.7374
1990's0 (0.00)18.2507
2000's7 (19.44)29.6817
2010's9 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL1
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W1
Conradi, R; Lee, PH; Shanmugasundaram, V1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Campillo, NE; Guerra, A; Páez, JA1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Christensen, LK; Hansen, JM1
Brunová, E; Dvorácek, K; Grafnetterová, J; Pavlik, F; Platilová, H; Slabochová, Z2
Ackermann, E1
Speck, B1
Christensen, LK; Skovsted, L1
Fabre, J; Petitpierre, B1
Ali, LM; Khalek, MM; Khalil, SA1
Sellers, E; Weser, JK1
Brunová, E; Platilová, H; Slabochová, Z1
Eipe, J1
Johnsgård, M; Pedersen, AO1
Ziegelasch, HJ1
Böttiger, LE; Westerholm, B1
Nimmo, J; Prescott, LF1
Walder, HR1
BRANOM, WT; HYMAN, AB; RUBIN, Z1
HUGULEY, CM1
ERSLEV, AJ1

Reviews

4 review(s) available for chloramphenicol and tolbutamide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Drug interactions with oral sulphonylurea hypoglycaemic drugs.
    Drugs, 1977, Volume: 13, Issue:1

    Topics: Allopurinol; Analgesics; Anticoagulants; Chloramphenicol; Chlorpropamide; Disulfiram; Drug Interactions; Ethanol; Glyburide; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Kinetics; Monoamine Oxidase Inhibitors; Novobiocin; Phenylbutazone; Phenytoin; Probenecid; Propranolol; Rifampin; Sulfonamides; Sulfonylurea Compounds; Tolbutamide

1977
Drug interactions with coumarin anticoagulants. 2.
    The New England journal of medicine, 1971, Sep-02, Volume: 285, Issue:10

    Topics: Allopurinol; Anabolic Agents; Animals; Anti-Bacterial Agents; Anticoagulants; Barbiturates; Chloral Hydrate; Chloramphenicol; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Coumarins; Dextrothyroxine; Diuretics; Drug Antagonism; Drug Synergism; Ethacrynic Acid; Ethanol; Glucagon; Glucocorticoids; Glutethimide; Humans; Oxyphenbutazone; Phenylbutazone; Quinidine; Quinine; Quinolines; Salicylates; Sulfinpyrazone; Sulfonamides; Thyroid Hormones; Tolbutamide

1971
Drugs affecting therapy with anticoagulants.
    The Medical clinics of North America, 1972, Volume: 56, Issue:1

    Topics: Anticoagulants; Chloramphenicol; Clofibrate; Contraceptives, Oral; Coumarins; Diuretics; Drug Interactions; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethanol; Heparin; Humans; Hypnotics and Sedatives; Phenylbutazone; Phenytoin; Salicylates; Thyroxine; Tolbutamide; Vitamin K

1972

Other Studies

32 other study(ies) available for chloramphenicol and tolbutamide

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Cheminformatic models to predict binding affinities to human serum albumin.
    Journal of medicinal chemistry, 2001, Dec-06, Volume: 44, Issue:25

    Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids

2001
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution

2009
Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.
    Bioorganic & medicinal chemistry letters, 2010, Jan-01, Volume: 20, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Cell Line; Cell Membrane Permeability; Humans; Models, Biological; Quantitative Structure-Activity Relationship; Skin Absorption

2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Interaction of tolbutamide and chloramphenicol in diabetic patients.
    International journal of clinical pharmacology and biopharmacy, 1977, Volume: 15, Issue:1

    Topics: Aged; Blood Glucose; Chloramphenicol; Diabetes Complications; Diabetes Mellitus; Drug Interactions; Female; Humans; Hypoglycemia; Insulin; Middle Aged; Tolbutamide; Urinary Tract Infections

1977
[Pharmacokinetics in liver cirrhosis].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1977, Jan-01, Volume: 32, Issue:1

    Topics: Aminopyrine; Biotransformation; Chloramphenicol; Coumarins; Half-Life; Humans; Kinetics; Liver Cirrhosis; Pharmaceutical Preparations; Phenylbutazone; Salicylates; Tolbutamide

1977
[Toxic bone-marrow insufficiency].
    Hamatologie und Bluttransfusion, 1975, Volume: 16

    Topics: Anemia, Aplastic; Anticonvulsants; Antineoplastic Agents; Benzene; Chloramphenicol; Gold; Radiation Injuries; Tolbutamide

1975
Inhibition of drug metabolism by chloramphenicol.
    Lancet (London, England), 1969, Dec-27, Volume: 2, Issue:7635

    Topics: Aged; Biotransformation; Carbon Isotopes; Chloramphenicol; Chromatography, Thin Layer; Dicumarol; Humans; Hypoglycemia; Male; Parkinson Disease; Phenytoin; Tolbutamide

1969
Chlorpropamide and chloramphenicol.
    Lancet (London, England), 1970, Apr-11, Volume: 1, Issue:7650

    Topics: Chloramphenicol; Chlorpropamide; Humans; Kidney; Tolbutamide

1970
Dissolution rate studies using the B.P. disintegration apparatus.
    The Journal of pharmacy and pharmacology, 1971, Volume: 23, Issue:2

    Topics: Capsules; Chloramphenicol; Solubility; Tablets; Technology, Pharmaceutical; Tolbutamide

1971
[Influencing the effect of Dirastan (tolbutamide) simultaneous administration of chloramphenicol in patients with diabetes and bacterial urinary tract inflammation (author's transl)].
    Casopis lekaru ceskych, 1974, Jan-18, Volume: 113, Issue:3

    Topics: Chloramphenicol; Diabetes Mellitus; Drug Interactions; Drug Synergism; Female; Humans; Hypoglycemia; Tolbutamide; Urinary Tract Infections

1974
[Tolbutamide serum levels im chloramfenicol treated diabetic females (author's transl)].
    Casopis lekaru ceskych, 1974, Nov-29, Volume: 113, Issue:48

    Topics: Aged; Chloramphenicol; Diabetes Complications; Diabetes Mellitus; Female; Humans; Middle Aged; Tolbutamide; Urinary Tract Infections

1974
[The consequence of the preparation factors for the effect of the drug].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1973, Apr-10, Volume: 93, Issue:10

    Topics: Absorption; Administration, Oral; Biopharmaceutics; Capsules; Chemistry, Pharmaceutical; Chloramphenicol; Digoxin; Humans; Nitrofurantoin; Pharmaceutical Preparations; Pharmaceutical Vehicles; Phenytoin; Structure-Activity Relationship; Suppositories; Tablets; Tablets, Enteric-Coated; Tetracycline; Time Factors; Tolbutamide

1973
[Extreme hypoglycemia during combined tolbutamide, n-1-butylbiguanide hydrochloride and chloramphenicol therapy].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1972, Jan-15, Volume: 27, Issue:2

    Topics: Age Factors; Aged; Biguanides; Chloramphenicol; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Drug Synergism; Female; Glucose; Heart Failure; Humans; Hypoglycemia; Hypoglycemic Agents; Intracranial Arteriosclerosis; Tolbutamide

1972
Aplastic anaemia. I. Incidence and aetiology.
    Acta medica Scandinavica, 1972, Volume: 192, Issue:4

    Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Child; Child, Preschool; Chloramphenicol; Female; Humans; Male; Middle Aged; Oxyphenbutazone; Phenylbutazone; Sweden; Tolbutamide

1972
Non-equivalent preparations of the same drug.
    Drug and therapeutics bulletin, 1971, Aug-13, Volume: 9, Issue:17

    Topics: Chloramphenicol; Dosage Forms; Humans; Nitrofurantoin; Oxytetracycline; Pharmaceutical Preparations; Phenindione; Phenobarbital; Phenylbutazone; Phenytoin; Tetracycline; Therapeutic Equivalency; Tolbutamide; Warfarin

1971
Generic inequivalence--clinical observations.
    Acta pharmacologica et toxicologica, 1971, Volume: 29 Suppl 3

    Topics: Absorption; Acetaminophen; Administration, Oral; Adult; Aspirin; Biopharmaceutics; Capsules; Chloramphenicol; Delayed-Action Preparations; Drug Compounding; Female; Humans; Hydrochlorothiazide; Phenacetin; Prednisone; Tablets; Tablets, Enteric-Coated; Tetracycline; Therapeutic Equivalency; Time Factors; Tolbutamide; Triamterene

1971
[Idiopathic and drug-induced acquired aplastic anemia. 2].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1970, Nov-10, Volume: 59, Issue:45

    Topics: Adult; Anemia, Aplastic; Aspirin; Bone Marrow Examination; Chloramphenicol; Chlorpheniramine; Chlorpromazine; Gold; Hemoglobins; Humans; Hydantoins; Middle Aged; Penicillins; Phenacetin; Prognosis; Sulfisoxazole; Switzerland; Tetracycline; Tolbutamide

1970
Chancriform pyoderma.
    Archives of dermatology, 1963, Volume: 87

    Topics: Chloramphenicol; Diabetes Mellitus; Humans; Pyoderma; Skin Ulcer; Staphylococcal Infections; Staphylococcal Skin Infections; Tolbutamide

1963
DRUG-INDUCED BLOOD DYSCRASIAS. II. AGRANULOCYTOSIS.
    JAMA, 1964, Jun-01, Volume: 188

    Topics: Agranulocytosis; Analgesics; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Antipyretics; Antithyroid Agents; Chloramphenicol; Chlorpromazine; Diagnosis; Drug Therapy; Humans; Phenindione; Phenothiazines; Tolbutamide; Toxicology

1964
DRUG-INDUCED BLOOD DYSCRASIAS. I. APLASTIC ANEMIA.
    JAMA, 1964, May-11, Volume: 188

    Topics: Acetazolamide; Anemia; Anemia, Aplastic; Anticonvulsants; Benzene; Chloramphenicol; Chlorothiazide; Chlorpropamide; Gold; Hematologic Diseases; Hexachlorocyclohexane; Phenylbutazone; Prednisone; Sulfamethoxypyridazine; Sulfisoxazole; Testosterone; Tolbutamide; Toxicology

1964